Record Second Quarter 2024 Revenue of $3.0 BillionSecond Quarter 2024 Diluted Earnings Per Share of $0.43 and Adjusted Diluted Earnings Per Share of $0.96, $0.08 Above ExpectationsSecond Quarter 2024 GAAP Net Income of $43.8 Million and Adjusted EBITDA of $267.8 Million, $7.8 Million Above Expectations18-month Backlog as of June 30, 2024 of $13.3 Billion Increased $501 Million Sequentially from the First Quarter of 2024 and Represents Record Levels for the Clean Energy and Infrastructure, Power Delivery and ...

KANSAS CITY, Mo., Aug. 01, 2024 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE:HRB) will report fourth quarter and fiscal 2024 full year results on Thursday, August 15, 2024, after the New York Stock Exchange market close. At that time, a copy of the press release and presentation will be available on the company's investor relations website at https://investors.hrblock.com/. A conference call for analysts, institutional investors, and shareholders will be held at 4:30 p.m. Eastern time on Thursday, August 15, 2 ...

- Revenues Increase 78% to $145.1 Million - Fair Market Value Loss of $148.0 Million, Resulting in Net Loss of $199.7 Million, or $0.72 Loss per Diluted Share - Adjusted EBITDA Decreases to a Loss of $85.1 Million Fort Lauderdale, FL, Aug. 01, 2024 (GLOBE NEWSWIRE) -- MARA (NASDAQ:MARA) ("MARA" or the "Company"), a global leader in leveraging digital asset compute to support the energy transformation, reported its financial and operational results for the quarter ended June 30, 2024. Second Quarter 2024 Fin ...

文章核心观点 - 公司在第二季度取得了强劲的业绩表现,包括与数据中心客户签署了2.2GW的新协议,并完成了976MW的风电、太阳能和储能项目的建设或收购 [1][5] - 公司预计2024年调整后EBITDA和调整后每股收益将达到指导区间的上半部分,并维持了未来几年的增长目标 [3][6][7] - 公司的业务模式具有很强的抗风险能力,能够确保未来几年的强劲增长 [3] 根据目录分别总结 战略成就 - 公司已与技术客户签署了8.1GW的协议,包括输电和配电、可再生能源电力购买协议(PPA)和零售供应 [5] - 公司的PPA订单量达到12.6GW,其中5.1GW正在建设中 [5] - 公司在第二季度新签署了1GW的长期PPA,并完成了976MW的新项目建设或收购 [5] 财务业绩 - 第二季度公司的调整后EBITDA和调整后每股收益同比分别增长14.6%和81% [4] - 公司预计2024年调整后EBITDA和调整后每股收益将达到指导区间的上半部分 [6][7] - 公司维持了未来几年的调整后EBITDA和调整后每股收益的增长目标 [6][7] 财务状况和展望 - 公司的财务状况良好,流动性充足 [30] - 公司预计未来几年业务将保持强劲增长 [3][6][7]

ROCKVILLE, Md., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced it has resubmitted its New Drug Application (NDA) for its apomorphine infusion device (SPN-830) for the continuous treatment of motor fluctuations (OFF episodes) in Parkinson's disease (PD). Supernus believes it has addressed the U.S. Food and Drug Administrat ...

BETHESDA, Md., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Host Hotels & Resorts, Inc. (NASDAQ:HST) (the "Company"), the nation's largest lodging real estate investment trust, today provided an updated investor presentation for second quarter 2024 results. The investor presentation can be found on the Investor Relations section on the Company's website at https://www.hosthotels.com/#key-investors-materials. ABOUT HOST HOTELS & RESORTS Host Hotels & Resorts, Inc. is an S&P 500 company and is the largest lodging real e ...

DELAWARE, Ohio, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, today announced it has sold Delta Petroleum Company, Inc. ("Delta"), a North American filling and logistics services business, to PSC Group LLC, a North American leader in product handling, site logistics, railcar repair, and sustainability services for the petrochemical, refining, and marine industries. "We are happy to have worked with the PSC Group in a transact ...

NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (Euronext Growth: ALCLS - NASDAQ:  CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Cellectis' CLLS52 (alemtuzumab), an Investigational Medicinal Product (IMP) used as part of the lymphodepletion regimen associated with UCART22, evaluated in th ...

FORT WASHINGTON, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, will broadcast live on its website, www.TollBrothers.com, a conference call to discuss results for its third quarter ended July 31, 2024. The call is scheduled for 8:30 a.m. (ET) on Wednesday, August 21, 2024 and will be hosted by Douglas C. Yearley, Jr., chairman and chief executive officer. The Company will announce its third quarter FY 2024 results after the market close o ...

DESIGNATED NEWS RELEASEVANCOUVER, BC, Aug. 1, 2024 /PRNewswire/ - Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) ("URC" or the "Company") is pleased to announce the completion of its previously announced acquisition of an additional royalty on a portion of the Churchrock uranium project ("Churchrock Project") owned indirectly by Laramide Resources Ltd. ("Laramide") in New Mexico, USA.  The Churchrock Project is an advanced stage, in-situ recovery uranium project located in the Grants Mineral Belt of New Me ...